Eric Honroth, the President and CEO of AngioDynamics Inc., recently filed a Form 3 with the SEC. This filing is significant as it details his ownership status and responsibilities within the company. Such disclosures are crucial for maintaining transparency and accountability in corporate governance.

AngioDynamics Inc. is a company known for its work in the surgical and medical instruments and apparatus sector. The company is incorporated in Delaware and operates from Latham, New York. It is listed under the Central Index Key number 0001275187.

The filing indicates that Honroth has no securities owned as of the report date of November 2, 2026. It states, "no securities owned: 1," which may imply that he holds a position of influence but has not disclosed ownership of specific securities at this time.

This filing may affect various stakeholders, including shareholders and potential investors, as it emphasizes the importance of executive accountability. It also highlights the regulatory requirements that executives must adhere to, ensuring that they are transparent about their roles and any potential conflicts of interest.

The filing does not say what happens next, but it is part of a series of disclosures that executives are required to make under the Securities Exchange Act of 1934.